کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2754558 | 1149788 | 2011 | 11 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Standard Therapy for Patients With Myelodysplastic Syndromes
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
بیهوشی و پزشکی درد
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Standard Therapy for Patients With Myelodysplastic Syndromes Standard Therapy for Patients With Myelodysplastic Syndromes](/preview/png/2754558.png)
چکیده انگلیسی
The myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders characterized by cytopenias, dysplastic changes in the hematopoietic precursors, and an increased risk of evolving into acute leukemia. Treatment for patients with MDS ranges from supportive care with blood products and/or growth factors up to allogeneic stem cell transplantation. Over the past decade, several novel therapeutic agents have been approved for clinical use. In this article, the current approach for the management of patients with MDS according to their risk category is described and mainly focuses on approved novel agents.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Lymphoma Myeloma and Leukemia - Volume 11, Issue 4, August 2011, Pages 303–313
Journal: Clinical Lymphoma Myeloma and Leukemia - Volume 11, Issue 4, August 2011, Pages 303–313
نویسندگان
Ali Al-Ameri, Mohamad Cherry, Guillermo Garcia-Manero, Alfonso Quintás-Cardama,